Document is current
Any future updates will be listed below
-
Authors
Ibáñez, Agustín https://orcid.org/0000-0001-6758-5101
Duran-Aniotz, Claudia
Migeot, Joaquín
Báez, Sandra https://orcid.org/0000-0003-0875-1709
Fittipaldi, Sol https://orcid.org/0000-0001-7704-3349
Coronel-Oliveros, Carlos
Eyre, Harris A.
Udeh-Momoh, Chinedu
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Alladi, Suvarna
Sandi, Carmen https://orcid.org/0000-0001-7713-8321
Robertson, Ian H.
Franzen, Sanne https://orcid.org/0000-0002-4461-5109
Farombi, Temitope
Montalvo Ortiz, Janitza L. https://orcid.org/0000-0002-7657-8365
Seshadri, Sudha https://orcid.org/0000-0001-6135-2622
Court, Felipe
Valdes-Sosa, Pedro https://orcid.org/0000-0001-5485-2661
Xu, Jiayuan https://orcid.org/0000-0001-9473-1047
Yu, Chunshui
Grinberg, Lea
Lawlor, Brian
Sachdev, Perminder S.
Yaffe, Kristine
Hachinski, Vladimir
Friston, Karl https://orcid.org/0000-0001-7984-8909
Tagliazucchi, Enzo
Santamaría-García, Hernando https://orcid.org/0000-0001-9422-3579
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (Provided in the ms)
NIH/NIA provided in the ms
- License Information
-
More Information
Article History
Received: 9 May 2025
Accepted: 14 November 2025
First Online: 11 December 2025
Competing interests
: HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. CS is a member of the scientific advisory board of Amazentis and Vandria and has given lectures sponsored by Schwabe Pharma. SF has received consulting fees from Biogen (2022). The other authors declare no competing interests.
